$26.46
$1.02
(4.01%)
Quote as of 4:00 PM EST on 02/13/12
Acorda Therapeutics, Inc.
NASDAQ:ACOR
|
$26.46
$1.02
(4.01%)
|
|
| Today's Open | $25.72 |
|---|---|
| Previous Close | $25.44 |
| Daily Range | $25.72 - $26.54 |
| 52-Week Range | $18.36 - $33.48 |
| Market Cap | $1.05B |
| P/E Ratio | 47.11 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 547,735 |
| Average Daily Volume | 540,265 |
| Current FY EPS | $0.62 |
ACOR Information
| Description |
|---|
| A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
3 Biotech Buyout Candidates for 2012
US Stock Futures: HOT STOCKS TO WATCH
Big Potential? Takeover Targets With Solid Profitability
Biogen Idec Passes This Key Test
Modest Growth, Less-Than-Modest Stock Drop
After Hours: Dendreon's Shares Crushed Again
Invest in Biotechs Going After Unmet Needs
Brain Disorders: 3 Biotech Stocks at the Forefront
Afternoon Roundup: Today's Top Stories
Biogen, Acorda MS Drug Gets Conditional European Approval
